Despite the promise, chaperone therapies face several challenges: - Specificity: Ensuring that the chaperone binds only to the target protein without affecting other proteins. - Delivery: Efficiently delivering the chaperone to the desired tissue or cellular compartment. - Stability: Maintaining the stability and activity of the chaperone in the biological environment. - Regulatory Approval: Navigating the complex regulatory landscape to achieve approval for clinical use.
